Biomarkers of immunotherapy in non‑small cell lung cancer (Review)-Reference-Cited by-同舟云学术

Biomarkers of immunotherapy in non‑small cell lung cancer (Review)

Published:2020-08-20 Issue:5 Volume:20 Page:1-1
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Wang Lingling¹,Hu Yue²,Wang Shengchao³,Shen Jiali²,Wang Xiaochen¹

Affiliation:

1. Department of Surgical Oncology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China

2. Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, P.R. China

3. Department of Gynecological Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial Intelligence and Machine Learning in Predicting the Response to Immunotherapy in Non-small Cell Lung Carcinoma: A Systematic Review;Cureus;2024-05-28

2. Plasma Proteome–Based Test for First-Line Treatment Selection in Metastatic Non–Small Cell Lung Cancer;JCO Precision Oncology;2024-03

3. Withaferin A Increases the Effectiveness of Immune Checkpoint Blocker for the Treatment of Non-Small Cell Lung Cancer;Cancers;2023-06-07

4. B cell‐dependent subtypes and treatment‐based immune correlates to survival in stage 3 and 4 lung adenocarcinomas;FASEB BioAdvances;2023-02-16

5. Immunological markers for predicting the response to immunotherapy in non-small cell lung cancer;Advances in Molecular Oncology;2022-06-26